A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial

A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: The Breast - Volume 23, Issue 5, October 2014, Pages 656-662

Antonio Llombart-Cussac, Xavier Pivot, Laura Biganzoli, Hernan Cortes-Funes, Kathleen I. Pritchard, Jean-Yves Pierga, Ian Smith, Christoph Thomssen, Stefanie Srock, Miguel Sampayo, Javier Cortes,